Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production
- 1 August 2005
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 289 (2) , H813-H822
- https://doi.org/10.1152/ajpheart.00092.2005
Abstract
Insulin stimulates production of NO in vascular endothelium via activation of phosphatidylinositol (PI) 3-kinase, Akt, and endothelial NO synthase. We hypothesized that insulin resistance may cause imbalance between endothelial vasodilators and vasoconstrictors (e.g., NO and ET-1), leading to hypertension. Twelve-week-old male spontaneously hypertensive rats (SHR) were hypertensive and insulin resistant compared with control Wistar-Kyoto (WKY) rats (systolic blood pressure 202 ± 11 vs. 132 ± 10 mmHg; fasting plasma insulin 5 ± 1 vs. 0.9 ± 0.1 ng/ml; P < 0.001). In WKY rats, insulin stimulated dose-dependent relaxation of mesenteric arteries precontracted with norepinephrine (NE) ex vivo. This depended on intact endothelium and was blocked by genistein, wortmannin, or Nω-nitro-l-arginine methyl ester (inhibitors of tyrosine kinase, PI3-kinase, and NO synthases, respectively). Vasodilation in response to insulin (but not ACh) was impaired by 20% in SHR (vs. WKY, P < 0.005). Preincubation of arteries with insulin significantly reduced the contractile effect of NE by 20% in WKY but not SHR rats. In SHR, the effect of insulin to reduce NE-mediated vasoconstriction became evident when insulin pretreatment was accompanied by ET-1 receptor blockade (BQ-123, BQ-788). Similar results were observed during treatment with the MEK inhibitor PD-98059. In addition, insulin-stimulated secretion of ET-1 from primary endothelial cells was significantly reduced by pretreatment of cells with PD-98059 (but not wortmannin). We conclude that insulin resistance in SHR is accompanied by endothelial dysfunction in mesenteric vessels with impaired PI3-kinase-dependent NO production and enhanced MAPK-dependent ET-1 secretion. These results may reflect pathophysiology in other vascular beds that directly contribute to elevated peripheral vascular resistance and hypertension.Keywords
This publication has 59 references indexed in Scilit:
- AKT Participates in Endothelial Dysfunction in HypertensionCirculation, 2004
- Enhanced Vascular Activity of Endogenous Endothelin-1 in Obese Hypertensive PatientsHypertension, 2004
- Analysis of Insulin Signaling Pathways through Comparative Genomics. Mapping Mechanisms for Insulin Resistance in Type 2 (Non-Insulin-Dependent) Diabetes MellitusExperimental and Clinical Endocrinology & Diabetes, 2003
- Induction of plasminogen activator inhibitor 1 by the PPARα ligand, Wy-14,643, is dependent on ERK1/2 signaling pathwayThrombosis and Haemostasis, 2003
- α-lactorphin and β-lactorphin improve arterial function in spontaneously hypertensive ratsLife Sciences, 2002
- Correlation of endothelial function in large and small arteries in human essential hypertension.Journal Of Hypertension, 2001
- Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells.Journal of Clinical Investigation, 1996
- Growth regulatory properties of endothelinsPeptides, 1993
- Insulin Resistance in Essential HypertensionNew England Journal of Medicine, 1987
- Vascular Structure and Smooth Muscle Contractility in Experimental HypertensionJournal of Cardiovascular Pharmacology, 1987